Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480340 | 8644641 | I | 8480340-X | 20120521 | 20120620 | 20120630 | EXP | IT-TEVA-344983ISR | TEVA | 64 | YR | F | Y | 20120630 | MD | ITALY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480340 | 1020135280 | C | VENLAFAXINA DOC GENERICI | 2 | |||||||
| 8480340 | 1020135275 | PS | LITHIUM CARBONATE | 1 | ORAL | 300 MILLIGRAM; | 076170 | ||||
| 8480340 | 1020135279 | C | ZARELIS | 2 | ORAL | ||||||
| 8480340 | 1020135278 | C | CLONAZEPAM | 1 | |||||||
| 8480340 | 1020135276 | C | LAMOTRIGINE | 1 | ORAL | ||||||
| 8480340 | 1020135277 | C | SEROQUEL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8480340 | 1020135275 | MAJOR DEPRESSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8480340 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8480340 | ENURESIS |
| 8480340 | CONFUSIONAL STATE |
| 8480340 | ASTHENIA |
| 8480340 | ACCIDENTAL OVERDOSE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8480340 | 1020135275 | 20120514 | 20120530 |